Sign In
Buy MBIO
$0.741
-0.0201 (-2.64%)
At Close: Jun 03, 2026
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
04:05pm, Thursday, 27'th Feb 2025
WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medic
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
04:10pm, Tuesday, 11'th Feb 2025
WORCESTER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO) today announced that it has received notice from The Nasdaq Stock Market LLC (
Mustang Bio Announces Closing of $8 Million Public Offering
08:00am, Monday, 10'th Feb 2025
WORCESTER, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's med
Mustang Bio Announces Pricing of $8 Million Public Offering
07:00am, Thursday, 06'th Feb 2025
WORCESTER, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's med
Mustang Bio Announces Reverse Stock Split
08:00am, Tuesday, 14'th Jan 2025
WORCESTER, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's med
Mustang Bio Receives Positive Listing Determination from Nasdaq
08:30am, Tuesday, 12'th Nov 2024
WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's med
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
08:30am, Thursday, 07'th Nov 2024
MB-108 (HSV-1 oncolytic virus) is active and well tolerated in patients with recurrent glioblastoma in ongoing Phase 1 clinical trial
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
02:10pm, Thursday, 24'th Oct 2024
WORCESTER, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's med
Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)
08:00am, Friday, 28'th Jun 2024
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released Update Note on Enveric Bioscience
Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
04:01pm, Friday, 21'st Jun 2024
WORCESTER, Mass., June 21, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's med
Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
08:00am, Thursday, 20'th Jun 2024
WORCESTER, Mass., June 20, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's med
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
11:26am, Tuesday, 18'th Jun 2024
Updated data from a clinical study shows that treatment with Mustang Bio's (MBIO) experimental cell therapy achieved an overall response rate of 90% in patients with a rare form of blood cancer.
Why are Mustang Bio shares (MBIO) up almost 500%?
02:52am, Tuesday, 18'th Jun 2024
The Mustang Bio stock price closed on a high yesterday, trading at $0.75. The pharmaceutical company has gone vertical in the past 24 hours, climbing 476.9% to go from $0.13 to $0.75 in a single day.
Crude Oil Rises 1%; Mustang Bio Shares Spike Higher
12:16pm, Monday, 17'th Jun 2024
U.S. stocks traded mixed midway through trading, with the S&P 500 edging higher on Monday.
Why Is Mustang Bio (MBIO) Stock Up 347% Today?
12:07pm, Monday, 17'th Jun 2024
Mustang Bio (NASDAQ: MBIO ) stock is taking off on Monday after the clinical-stage biopharmaceutical company announced positive results from a study. The recent news includes favorable results from th
